Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Tibotec (part of Johnson & Johnson)

Tibotec website: www.tibotec.com

🔎 Run a search for “Tibotec (part of Johnson & Johnson)”

Get RSS feed of these results

All stories

Show me

Date order
▲
▼

Article

12 September 2006

Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"

Author: Compiled by Business & Human Rights Resource Centre

In August 2006, the Interfaith Center on Corporate Responsibility issued a report, "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"...The Business & Human Rights Resource Centre...

▹Read more

Related stories: Interfaith Center on Corporate Responsibility - new report on pharmaceutical firms' responses to AIDS
Related in-depth areas: ICCR AIDS report & responses
Related companies: Abbott Laboratories AstraZeneca Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly Gilead Sciences GlaxoSmithKline Hoffmann-La Roche (part of Roche) Johnson & Johnson Merck Novartis Pfizer Roche Sanofi-Aventis Schering-Plough Tibotec (part of Johnson & Johnson) Wyeth (part of Pfizer)

Story

14 August 2006

Interfaith Center on Corporate Responsibility - new report on pharmaceutical firms' responses to AIDS

▹See full story

Story

1 March 2005

GlaxoSmithKline, AstraZeneca, Merck, Pfizer & other firms join UK govt. in committing to increased access to essential medicines for poorest countries, including via differential pricing

▹See full story

Article

1 March 2005

[PDF] Increasing people’s access to essential medicines in developing countries: a framework for good practice in the pharmaceutical industry

Author: UK Department for International Development (DFID)

Responsibility for increasing access to essential medicines rests with the whole international community...In this context there is a particular role for pharmaceutical companies. As the producers of existing, and developers of new, medicines they can...